Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
Chengdu Kanghong Pharma

CTech 24/7

16:19 Trump's policy creates a window of opportunity for Israel in AI
11:14 Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option
10:31 How AI agents will transform work — and what humans must do to stay relevant
09:59 Intel-backed Ignite DeepTech launches first cohort in Israel

Chengdu Kanghong Pharma

2 stories about Chengdu Kanghong Pharma

Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company
27.09.18|Lilach BaumerThe company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery
Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima
21.11.17|Lilach BaumerThe Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Chengdu Kanghong Pharma

Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima